Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kirk Randal J
Relationship:   10% Owner
City:   Radford
State:   VA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   3,684,697    

Indirect Shares

   67,796,291      
Direct Value   $162,038,028    

Indirect Value

   $374,282,250      
Total Shares   71,480,988      
Total Value   $536,320,277      


Halozyme Therapeutics Inc $162,017,406 Alaunos Therapeutics $20,621 Halozyme Therapeutics Inc $162,017,406 Alaunos Therapeutics $20,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    0    

     Stock price went up :
    6   
    0    
     Stock price went down :
    8   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   46.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clinical Data Inc CLDA Director, 10% Owner 2011-04-12 0 2011-04-12 0    Premium*  
            Halozyme Therapeutics Inc HALO 10% Owner 2018-08-28 3,562,388 2018-08-28 6,629,464    Premium*  
            Precipio Inc PRPO 10% Owner 2012-02-03 0 2018-08-28 27,151    Premium*  
            Precigen Inc PGEN 0 2024-05-02 51,557,665    Premium*  
            Alaunos Therapeutics TCRT Director, 10% Owner 2015-12-31 122,309 2015-12-31 9,570,094    Premium*  
            Aquabounty Technologies, Inc. AQB 10% Owner 2020-02-13 0 2020-12-17 11,917    Premium*  
* Premium Members only  

Records found :    271         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 7 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-24 4 B $4.68 $508,459 I/I 108,645 151,032 2.64 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-27 4 S $18.22 $1,992,849 I/I (109,377) 2,154,470 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-08-25 4 B $2.50 $277,250 I/I 110,900 415,300 1.5 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-22 4 B $4.70 $541,379 I/I 115,187 953,541 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-11 4 B $5.27 $608,364 I/I 115,439 115,439 2.25 -
PGEN Precigen Inc   •       •       •   2023-08-16 4 B $1.51 $180,311 I/I 119,411 31,837,786 0.01 %
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-06-29 4 S $16.97 $2,077,654 I/I (122,431) 3,796,606 0 -
PGEN Precigen Inc Director   –       •       •   2023-02-22 4 OE $0.00 $0 I/I 123,152 31,252,316 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2015-12-11 4 B $29.83 $3,715,801 I/I 124,475 6,608,167 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-29 4 B $4.68 $585,562 I/I 125,120 1,010,201 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-12-31 4 A $6.54 $999,993 I/I 127,082 16,043,868 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2007-09-14 4 B $8.71 $1,112,206 I/I 127,693 3,693,406 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-07-31 4 A $7.76 $1,000,227 I/I 128,235 2,524,944 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-06-28 4 S $16.99 $2,181,261 I/I (128,385) 3,869,359 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-23 4 B $4.67 $600,683 I/I 128,626 150,445 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-08-11 4 B $18.85 $2,499,981 I/I 132,625 6,782,622 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-31 4 B $4.78 $648,369 I/I 135,642 154,438 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-07-10 4 OE $1.75 $238,525 I/I 136,300 1,436,186 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-08-30 4 A $6.65 $1,000,282 I/I 137,353 2,632,209 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-08 4 S $17.52 $2,570,499 I/I (146,718) 3,529,470 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-07 4 B $5.26 $779,727 I/I 148,237 1,142,758 2.64 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-07-26 4 S $17.30 $2,595,000 I/I (150,000) 3,645,729 0 -
CLDA Clinical Data Inc Director   –       •       •   2006-02-09 4 A $23.40 $3,588,507 I/I 153,355 153,353 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-21 4 S $17.15 $2,765,369 I/I (161,246) 2,894,871 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-09-30 4 A $5.99 $1,000,162 I/I 164,134 2,762,970 0 -
  271  Records found
  1   2   3   4   5   6   7  8   9   10   11      
  Page 7 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us